Related Experiment Video
Updated: Jun 19, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Angiokeratoma: a cutaneous marker of Fabry's disease
L M J Albano1, C Rivitti, D R Bertola
1Clinical Genetics Unit, Instituto da Criança, Hospital das Clínicas, FMUSP, São Paulo, Brazil. lilian.albano@icr.usp.br
Abstract:
The initial symptoms of Fabry's disease (FD) may seem harmless and may delay its diagnosis. A survey and screening for FD were performed on men with biopsy-proven angiokeratoma and some of their relatives (n = 29). Three patients were identified. Dermatologists should be aware of this prominent early feature and investigate unexplained cutaneous vascular lesions to detect FD.
Insights
Fabry's disease (FD) can have subtle early symptoms like angiokeratoma, delaying diagnosis. Early skin lesion screening in at-risk individuals can help identify FD patients sooner.
Area of Science:
- Dermatology
- Genetics
- Rare Diseases
Background:
- Fabry's disease (FD) is a rare genetic disorder.
- Initial symptoms of FD can be subtle, leading to diagnostic delays.
Purpose of the Study:
- To assess the prevalence of FD in men with angiokeratoma.
- To highlight the importance of dermatological screening for early FD detection.
Main Methods:
- A survey and screening study was conducted.
- Participants included men with biopsy-proven angiokeratoma and their relatives (n=29).
Main Results:
- Three patients with Fabry's disease were identified.
- Angiokeratoma was a significant early indicator in identified patients.
Conclusions:
- Dermatologists should consider FD when encountering unexplained cutaneous vascular lesions.
- Screening for FD in patients with angiokeratoma is crucial for timely diagnosis and management.
More Related Videos
09:14Isolation of Papillary and Reticular Fibroblasts from Human Skin by Fluorescence-activated Cell Sorting
Published on: May 7, 2019
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019